Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string’ test to detect oesophageal cancer earlier.
Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.
Inflammation can prevent infections and helps repair injuries. But for people with long-term inflammatory conditions, it can sometimes lead to cancer.
Hot drinks have hit headlines today, with new research sparking claims that hot tea ‘doubles the risk of oesophageal cancer’. But how hot is hot? And are the headlines anything to worry about?
Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease.
In this week’s cancer news there’s Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
We explore how oesophageal cancer affects different areas of the world and look at the reasons behind climbing rates of this disease.
We’re announcing the first winners of our most ambitious science funding awarding ever: The Grand Challenge
For this year’s World Cancer Day we’re looking at how the rates of 4 types of cancer vary around the world, and why.
Meet our new leaders, who are spearheading research to tackle some of the biggest questions we need to answer to help more people survive cancer.